Lineage Cell Therapeutics(LCTX)
CARLSBAD, CABiotechnology
Focus: Lineage Cell Therapeutics is a regenerative medicine biotech focused on cell therapy, with early-stage programs primarily in spinal cord injury. The company is public (NASDAQ: LCTX) and based in Carlsbad, CA.
Profile data last refreshed 23h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About Lineage Cell Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Lineage Cell Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Lineage Cell Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$9M
FY2025
Pipeline & Clinical Trials
Magnetic Resonance Imaging
Spinal Cord InjuriesClinical Trials (1)
NCT05919563LTFU Study of Subjects Who Received GRNOPC1
N/AHelp build intelligence for Lineage Cell Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.